Thermo Fisher Scientific to buy Olink in $3.1 billion deal

Thermo Fisher Scientific (TMO.N) would acquire Olink Holding AB (OLK.O) in a deal valued at $3.1 billion, the companies said on Tuesday, as the U.S. medical equipment maker seeks to boost its life sciences portfolio that helps drug discovery.